Study to characterise patients receiving benralizumab in the framework of an individualized access program in Spain

Trial Identifier:	D3250R00052
Sponsor:	AstraZeneca
NCTID::	NCT04126499
Start Date:	January 2020
Primary Completion Date:	May 2020
Study Completion Date:	May 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Spain	Madrid, Spain

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.